These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29877234)

  • 21. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
    Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.
    Sugita J
    Int J Hematol; 2019 Jul; 110(1):30-38. PubMed ID: 31104211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.
    Raiola AM; Risitano A; Sacchi N; Giannoni L; Signori A; Aquino S; Bregante S; Di Grazia C; Dominietto A; Geroldi S; Ghiso A; Gualandi F; Lamparelli T; Tedone E; Van Lint MT; Varaldo R; Ibatici A; Marani C; Marotta S; Guolo F; Avenoso D; Garbarino L; Pane F; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):119-126. PubMed ID: 29024804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and reduced intensity, TBI-free conditioning regimens in salvage transplantations.
    Wawrzyniak-Dzierżek E; Gajek K; Ślęzak A; Rybka B; Ryczan-Krawczyk R; Gorczyńska E; Kałwak K; Ussowicz M
    Adv Clin Exp Med; 2019 Sep; 28(9):1223-1228. PubMed ID: 31430069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning.
    Jaiswal SR; Chakrabarti A; Chatterjee S; Bhargava S; Ray K; O'Donnell P; Chakrabarti S
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):499-504. PubMed ID: 26612281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.
    Sugita J; Kawashima N; Fujisaki T; Kakihana K; Ota S; Matsuo K; Miyamoto T; Akashi K; Taniguchi S; Harada M; Teshima T;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1646-52. PubMed ID: 26093044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Prata PH; Resche-Rigon M; Blaise D; Socié G; Rohrlich PS; Milpied N; Turlure P; Nguyen S; Sirvent A; Bulabois CE; Berceanu A; Charbonnier A; Chevallier P; Bay JO; Neven B; Jubert C; Mohty M; Rubio MT; Peffault de Latour R
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1798-1802. PubMed ID: 31129355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
    Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
    Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation].
    Chen Y; Xu L; Liu D; Liu K; Chen H; Zhang X; Wang F; Wang J; Wang Y; Han W; Chen Y; Yan C; Zhao T; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):710-4. PubMed ID: 25511404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can haploidentical transplantation meet all patients' needs?
    Weisdorf D
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):410-413. PubMed ID: 30466758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Albert MH; Sirin M; Hoenig M; Hauck F; Schuetz C; Bhattacharyya R; Stepensky P; Jacoby E; Güngör T; Beier R; Schulz A
    Bone Marrow Transplant; 2021 Sep; 56(9):2248-2258. PubMed ID: 33967276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantation.
    Solomon SR; Sanacore M; Zhang X; Brown S; Holland K; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1828-34. PubMed ID: 25064745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.
    Wang Y; Liu DH; Liu KY; Xu LP; Zhang XH; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Sun YQ; Huang XJ
    Cancer; 2013 Mar; 119(5):978-85. PubMed ID: 23097265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide].
    Sugita J
    Rinsho Ketsueki; 2020; 61(9):1402-1410. PubMed ID: 33162542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment of myelodysplastic syndromes complicated by myeloid sarcoma with haploidentical allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide].
    Furumoto T; Makiyama J; Toriyama E; Niino D; Hata T; Moriuchi Y; Miyazaki Y
    Rinsho Ketsueki; 2022; 63(5):341-346. PubMed ID: 35662155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.